Study of Fas (CD95) and FasL (CD178) polymorphisms in liver transplant recipients

Tissue Antigens

Volumn 67, Issue 2, 2006, Pages 117-126

  Marin L A ^a   Muro, M ^a   Moya Quiles, M R ^a   Miras, M ^a   Minguela, A ^a   Bermejo, J ^a   Sanchez Bueno, F ^a   Parrilla, P ^a   Alvarez Lopez M R ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Acute rejection; Fas; FasL; Graft survival; Single nucleotide polymorphism

Indexed keywords

ANTIGEN; CD178 ANTIGEN; FAS ANTIGEN; FAS LIGAND; RECEPTOR; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; ALLELE; APOPTOSIS; ARTICLE; CHRONIC GRAFT REJECTION; FEMALE; GENE AMPLIFICATION; GENETIC POLYMORPHISM; GENOTYPE; GRAFT SURVIVAL; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECIPIENT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; TRANSPLANTATION TOLERANCE;

ADULT; ANTIGENS, CD95; ANTIGENS, DIFFERENTIATION; COHORT STUDIES; DISEASE PROGRESSION; FAS LIGAND PROTEIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TIME FACTORS; TUMOR NECROSIS FACTORS;

EID: 33644926711     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.00538.x     Document Type: Article

References (41)

1. Cohen JJ Apoptosis: mechanisms of life and death in the immune system J Allergy Clin Immunol 1999 103 548 54
2. Mogil RJ Radvanyi L Gonzalez-Quintial R et al. Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo Int Immunol 1995 7 1451 8
3. Lowin B Mattman C Hahne M Tschopp J Comparison of Fas(Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes Int Immunol 1996 8 57 63
4. Kabelitz D Apoptosis, graft rejection, and transplantation tolerance Transplantation 1998 65 869 75
5. Ito H Kasagi N Shomori K Osaki M Adachi H Apoptosis in the human allografted kidney. Analysis by terminal deoxynucleotidyl transferase-mediated DUTP-botin nick end labeling Transplantation 1995 60 794 8
6. Laine J Etelamaki P Holmberg C Dunkel L Apoptotic cell death in human chronic renal allograft rejection Transplantation 1997 63 101 5
7. Sharland A Yan Y Wang C et al. Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance Transplantation 1999 68 1736 45
8. Itoh N Yonehara S Ishii A et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis Cell 1991 66 233 43
9. Krammer PH CD95's deadly mission in the immune system Nature 2000 407 789 95
10. Takahashi T Tanaka M Inazawa J Abe T Suda T Nagata S Human Fas ligand: gene structure, chromosomal location and species specificity Int Immunol 1994 6 1567 74
11. Pan TL Goto S Lin YC et al. The fas and fas ligand pathways in liver allograft tolerance Clin Exp Immunol 1999 118 180 7
12. Li XK Okuyama T Tamura A et al. Prolonged survival of recipient rats with Fas-ligand-transfected liver allografts by using HVJ-liposome Transplant Proc 1998 30 943
13. Hiroyasu S Shiraishi M Koji T Mamadi T Sugawa H Muto Y Analysis of the Fas system and Bcl-2 in rat liver allograft rejection J Surg Res 1999 84 204 11
14. Rivero M Crespo J Mayorga M Fabrega E Casafont F Pons-Romero F Involvement of the Fas system in liver allograft rejection Am J Gastroenterol 2002 97 1501 6
15. Marin L Minguela A Moya-Quiles MR et al. Expression of CD95 and apoptosis induction in peripheral blood cells from liver graft recipients Transplant Proc 2002 34 280 2
16. Huang QR Morris D Manolios N Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene Mol Immunol 1997 34 577 82
17. Huang QR Danis V Lassere M Edmonds J Manolios N Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients Rheumatology (Oxford) 1999 38 645 51
18. Wu J Alizadeh BZ Veen TV Meijer JW Mulder CJ Pena AS Association of FAS (TNFRSF6)-670 gene polymorphism with villous atrophy in coeliac disease World J Gastroenterol 2004 10 717 20
19. Huang QR Manolios N Investigation of the -1377 polymorphism on the Apo-1/Fas promoter in systemic lupus erythematosus patients using allele-specific amplification Pathology 2000 32 126 30
20. Bolstad AI Wargelius A Nakken B Haga HJ Jonsson R Fas and Fas ligand gene polymorphisms in primary Sjogren's syndrome J Rheumatol 2000 27 2397 405
21. Minguela A Marin L Torio A et al. CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant Hum Immunol 2000 61 658 69
22. Mor E Solomon H Gibbs JF et al. Acute cellular rejection following liver transplantation: clinical pathologic features and effect on outcome Semin Liver Dis 1992 12 28 40
23. Adams DH Neuberger JM Patterns of graft rejection following liver transplantation J Hepatol 1990 10 113 9
24. Wiesner RH Ludwig J Krom RA Hay JE van Hoek B Hepatic allograft rejection: new developments in terminology, diagnosis, prevention, and treatment Mayo Clin Proc 1993 68 69 79
25. Ontanon J Muro M Garcia-Alonso AM et al. Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients Transplantation 1998 65 1047 53
26. Adams DH Neuberger JM Treatment of acute rejection Semin Liver Dis 1992 12 80 8
27. Muro M Alvarez-Lopez MR Torio A et al. HLA-DRB1 and -DQB1 polymorphism in liver recipients: relationship between HLA-DQB1*0302 allele frequency and acute rejection Hum Immunol 1997 56 70 6
28. Pinti M Troiano L Nasi M et al. Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians Cell Death Differ 2002 9 431 8
29. Stuck BJ Pani MA Besrour F et al. Fas ligand gene polymorphisms are not associated with Hashimoto's thyroiditis and Graves' disease Hum Immunol 2003 64 285 9
30. Niino M Kikuchi S Fukazawa T Miyagishi R Yabe I Tashiro K An examination of the Apo-1/Fas promoter Mva I polymorphism in Japanese patients with multiple sclerosis BMC Neurol 2002 2 8
31. Seo JC Han SW Yin CS et al. Evaluation of a Apo-1/Fas promoter polymorphism in Korean stroke patients Exp Mol Med 2002 34 294 8
32. McLaren AJ Marshall SE Haldar NA et al. Adhesion molecule polymorphisms in chronic renal allograft failure Kidney Int 1999 55 1977 82
33. Chevrier D Giral M Braud V et al. Effects of MHC-encoded TAP1 and TAP2 gene polymorphism and matching on kidney graft rejection Transplantation 1995 60 292 6
34. Marshall SE Welsh KI The role of cytokine polymorphisms in rejection after solid organ transplantation Genes Immun 2001 2 297 303
35. Slavcheva E Albanis E Jiao Q et al. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection Transplantation 2001 72 935 40
36. Poli F Piccolo G Scalamogna M Genetic polymorphisms influencing therapy and susceptibility to rejection in organ allograft recipients BioDrugs 2002 16 11 7
37. Behrmann I Walczak H Krammer PH Structure of the human APO-1 gene Eur J Immunol 1994 24 3057 62
38. Shuai K Interferon-activated signal transduction to the nucleus Curr Opin Cell Biol 1994 6 253 9
39. Gao J Morrison DC Parmely TJ Russell SW Murphy WJ An interferon-gamma- activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide J Biol Chem 1997 272 1226 30
40. Xu X Fu XY Plate J Chong AS IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression Cancer Res 1998 58 2832 7
41. Crispe IN Dao T Klugewitz K Mehal WZ Metz DP The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol Rev 2000 174 47 62